IngentaConnect Daptomycin and the risk of eosinophilic pneumonia
Links shared publicly online about this topic.
- 951total visits
IngentaConnect Daptomycin and the risk of eosinophilic pneumonia
View full resource at ingentaconnect.com
Most Recently Shared on August 13, 2010 at 10:49 am By:
Daptomycin and the risk of eosinophilic pneumonia: (Source: Reactions)MedWorm Message: Register for MedMatcha, Med... http://bit.ly/9ofa9b
Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
fda.gov — “Cases of serious, potentially fatal pneumonia associated with the IV antibacterial drug Cubicin.” View full resource at fda.gov
Most Recently Shared on July 30, 2010 at 11:40 am By:
Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia: Cases of serious, potentially ... http://bit.ly/bTeVBr
FDA MedWatch - Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia - Drugs.com MedNews
drugs.com — “ROCKVILLE, Md., July 29, 2010-ISSUE FDA notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia during treatmen” View full resource at drugs.com
Most Recently Shared on July 30, 2010 at 11:39 am By:
FDA MedWatch - Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia: ROCKVILLE, Md., J... http://bit.ly/b9uuaB
FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia
drugs.com — “FDA Alert: Cubicin (daptomycin): Drug Safety Communication - Risk of Eosinophilic Pneumonia” View full resource at drugs.com
Most Recently Shared on July 30, 2010 at 2:34 am By:
FDA Alert - FDA Warns of Eosinophilic Pneumonia Risk with Cubicin (daptomycin) - http://bit.ly/d3yDrx
Medical News: FDA Finds Pneumonia Risk with Daptomycin - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “The FDA said that the intravenous antibiotic daptomycin (Cubicin) may be linked to an increased risk of eosinophilic pneumonia -- a rare but serious potential side effect -- and requested that a new d” View full resource at medpagetoday.com
Most Recently Shared on July 29, 2010 at 5:41 pm By:
FDA Finds Pneumonia Risk with Daptomycin (MedPage Today) -- The FDA said that the intravenous antibiotic daptomycin (Cu.. http://dld.bz/ppsG
FDA warns of eosinophilic pneumonia risk with Cubicin - ONA
oncologynurseadvisor.com — “The FDA has notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia while receiving the antibiotic Cubicin (daptomycin, from Cubist).” View full resource at oncologynurseadvisor.com
Most Recently Shared on July 29, 2010 at 4:11 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA warns of eosinophilic pneumonia risk with Cubicin http://goo.gl/fb/EeN7V
FDA warns of eosinophilic pneumonia risk with Cubicin - MPR
empr.com — “The FDA has notified healthcare professionals and patients about the potential for developing eosinophilic pneumonia while receiving the antibiotic Cubicin (daptomycin, from Cubist).” View full resource at empr.com
Most Recently Shared on July 29, 2010 at 4:02 pm By:
MPR News: FDA warns of eosinophilic pneumonia risk with Cubicin: The FDA has notified healthcare professionals and... http://bit.ly/9UDpdZ
Advertisement
